NASDAQ:SSRX - 3SBio Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$16.59Today's RangeN/A52-Week Range$10.15 - $16.70VolumeN/AAverage Volume149,084 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email 3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub. Receive SSRX News and Ratings via Email Sign-up to receive the latest news and ratings for SSRX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:SSRX Previous Symbol CUSIPN/A CIK1383790 Webwww.3sbio.com Phone+86-24-25811820Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable 3SBio (NASDAQ:SSRX) Frequently Asked Questions What is 3SBio's stock symbol? 3SBio trades on the NASDAQ under the ticker symbol "SSRX." How were 3SBio's earnings last quarter? 3SBio Inc (NASDAQ:SSRX) issued its earnings results on Monday, March, 18th. The biotechnology company reported $0.12 EPS for the quarter, missing the Zacks' consensus estimate of $0.14 by $0.02. The biotechnology company earned $26.30 million during the quarter, compared to analysts' expectations of $25.63 million. View 3SBio's Earnings History. Has 3SBio been receiving favorable news coverage? News articles about SSRX stock have trended somewhat positive this week, according to InfoTrie. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. 3SBio earned a news impact score of 1.2 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. What other stocks do shareholders of 3SBio own? Based on aggregate information from My MarketBeat watchlists, some companies that other 3SBio investors own include Regeneron Pharmaceuticals (REGN), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP), Ardelyx (ARDX) and ArQule (ARQL). Who are 3SBio's key executives? 3SBio's management team includes the folowing people: Jing Lou, Executive Chairman of the Board, Chief Executive Officer (Age 54)Bo Tan, Chief Financial Officer, Executive Vice President, Executive Director (Age 44)Fei You, Director - Finance (Age 38)Weihonghas Xiao, Chief Operating Officer (Age 48)Dongmei Su, Senior Vice President, Executive Director (Age 46)Zhenping Zhu MD. Ph.D., Chief Scientific Officer, President - Research & Development (Age 52)Bin Huang, Vice President, Executive Director (Age 56)Xin Ma, Vice President - Human Resources (Age 51)Yongfu Chen, Vice President (Age 60)Kevin Liu, Vice President (Age 47) How do I buy shares of 3SBio? Shares of SSRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is 3SBio's official website? The official website for 3SBio is http://www.3sbio.com. How can I contact 3SBio? 3SBio's mailing address is No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone, SHENYANG, LIA 110027, China. The biotechnology company can be reached via phone at +86-24-25811820. MarketBeat Community Rating for 3SBio (NASDAQ SSRX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 112 (Vote Outperform)Underperform Votes: 99 (Vote Underperform)Total Votes: 211MarketBeat's community ratings are surveys of what our community members think about 3SBio and other stocks. Vote "Outperform" if you believe SSRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/22/2019 by MarketBeat.com StaffFeatured Article: What is included in the gross domestic product?